We are live on
!
Find out more
MCM
Marsico Capital Management Portfolio holdings
AUM
$3.4B
1-Year Est. Return
51.58%
This Fund
S&P 500
This Quarter
Est. Return
+6.47%
1 Year Est. Return
+51.58%
3 Year Est. Return
+243.93%
5 Year Est. Return
+321.58%
10 Year Est. Return
+1,831.46%
AUM
$15.9B
AUM Growth
–
Cap. Flow
+$15.9B
Cap. Flow
% of AUM
99.53%
Top 10 Holdings %
Top 10 Hldgs %
37.48%
Holding
97
New
97
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$888M |
| 2 |
Biogen
BIIB
|
+$854M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$688M |
| 4 |
MON
Monsanto Co
MON
|
+$612M |
| 5 |
Citigroup
C
|
+$580M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 23.56% |
| 2 | Financials | 15.96% |
| 3 | Healthcare | 13.37% |
| 4 | Industrials | 12.33% |
| 5 | Communication Services | 11.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Ecolab
ECL
$78.6B
| $17.2M | 0.11% |
+202,480
| New | +$17.1M |
|
77
Ralph Lauren
RL
$22.6B
| $16.6M | 0.1% |
+95,481
| New | +$16.8M |
|
78
TransDigm Group
TDG
$71.9B
| $16.5M | 0.1% |
+105,029
| New | +$15.8M |
|
|
CELG
79
DELISTED
Celgene Corp
CELG
| $16.3M | 0.1% |
+279,110
| New | +$16.8M |
|
80
Monster Beverage
MNST
$91.5B
| $15M | 0.09% |
+1,484,310
| New | +$13.9M |
|
81
Seagate
STX
$189B
| $14.8M | 0.09% |
+329,483
| New | +$13.3M |
|
82
BioMarin Pharmaceuticals
BMRN
$11.6B
| $14.5M | 0.09% |
+259,319
| New | +$16.2M |
|
|
QIWI
83
DELISTED
QIWI PLC
QIWI
| $13.3M | 0.08% |
+571,798
| New | +$10.7M |
|
84
Equinix
EQIX
$102B
| $12.7M | 0.08% |
+68,742
| New | +$14.3M |
|
85
Mercado Libre
MELI
$96.3B
| $12.5M | 0.08% |
+116,018
| New | +$12.5M |
|
|
BEAV
86
DELISTED
B/E Aerospace Inc
BEAV
| $12.3M | 0.08% |
+270,256
| New | +$12.2M |
|
87
Berkshire Hathaway Class B
BRK.B
$1.11T
| $9.78M | 0.06% |
+87,398
| New | +$9.62M |
|
88
Brown & Brown
BRO
$24B
| $8.95M | 0.06% |
+555,448
| New | +$8.79M |
|
89
Estee Lauder
EL
$30.6B
| $8.85M | 0.06% |
+134,498
| New | +$9.18M |
|
90
SBA Communications
SBAC
$19B
| $8.24M | 0.05% |
+111,144
| New | +$8.47M |
|
91
Incyte
INCY
$24B
| $8.13M | 0.05% |
+369,562
| New | +$8.07M |
|
|
LUX
92
DELISTED
Luxottica Group
LUX
| $6.4M | 0.04% |
+126,586
| New | +$6.55M |
|
|
MODN
93
DELISTED
MODEL N, INC.
MODN
| $4.75M | 0.03% |
+203,500
| New | +$4.09M |
|
94
Pricesmart
PSMT
$6.08B
| $4.6M | 0.03% |
+52,502
| New | +$4.53M |
|
95
United Parks & Resorts
PRKS
$2.15B
| $3.51M | 0.02% |
+100,000
| New | +$3.59M |
|
|
KMI.WS
96
DELISTED
Kinder Morgan Inc
KMI.WS
| $1.69M | 0.01% |
+330,553
| New | +$1.81M |
|
|
WFM
97
DELISTED
Whole Foods Market Inc
WFM
| $779K | ﹤0.01% |
+15,136
| New | +$730K |
|
Similar funds
BG
OAM
DFO
VFCM
CIA
EFM
JGC
PWP
Marsico Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Marsico Capital Management, which disclosed 97 positions worth $15.9B. Its ten largest holdings account for 37% of the portfolio.
Its largest position is Gilead Sciences: 17,041,344 shares worth $873M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 24% of assets, followed by Financials and Healthcare.
- Marsico Capital Management's largest Q2 2013 buy was Gilead Sciences: 17,041,344 shares worth $873M.
- Marsico Capital Management's ten largest holdings make up 37% of its $15.9B portfolio in Q2 2013.
- Marsico Capital Management disclosed 97 positions in Q2 2013, its first 13F filing on record.
Based on Marsico Capital Management's 13F filing for Q2 2013, filed 14 Aug 2013.